Bohring-Opitz syndrome

From WikiMD.org
Jump to navigation Jump to search

Bohring-Opitz Syndrome (pronounced: bohr-ing op-itz sin-drohm) is a rare genetic disorder first described by Axel Bohring and others in 1999.

Etymology

The syndrome is named after the German pediatrician Axel Bohring and the Dutch pediatrician Bianca Opitz, who were the first to describe the condition.

Definition

Bohring-Opitz Syndrome is a rare genetic disorder characterized by distinctive facial features, growth delays, intellectual disability, and various physical abnormalities. The syndrome is caused by mutations in the ASXL1 gene.

Symptoms

The symptoms of Bohring-Opitz Syndrome can vary greatly from person to person. However, common symptoms include:

Causes

Bohring-Opitz Syndrome is caused by mutations in the ASXL1 gene. This gene provides instructions for making a protein that is involved in regulating other genes. Mutations in the ASXL1 gene disrupt the normal development of many parts of the body, leading to the signs and symptoms of Bohring-Opitz Syndrome.

Diagnosis

Diagnosis of Bohring-Opitz Syndrome is based on clinical features and confirmed by genetic testing to identify a mutation in the ASXL1 gene.

Treatment

There is currently no cure for Bohring-Opitz Syndrome. Treatment is supportive and based on the signs and symptoms present in each person. This may include physical therapy, speech therapy, and educational services.

See Also

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski